Global Sickle Cell Treatment market is segmented by Treatment Modality (Bone Marrow Transplant, Blood Transfusion, and Pharmacotherapy), End User (Hospitals, Specialty Clinics, and Others),Regional Forecasts 2021-2027

Published	Pages	Publisher	Report code
Sep 2021	200	Bizwit Research	ASDR-589676

Published: Sep 2021 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-589676

Bristol Myers Squibb Co.
Global Blood Therapeutics Inc.
Bluebird Biotechnology
F.Hoffmann-La Roche
Emmaus Medical Inc.
Eli-Lilly and Co.
Baxter Inc.
Medunik USA.Inc.
Addmedica Inc.

LAMEA Sickle Cell Disease Treatment Market Size, Share & Industry Trends Analysis Report By Treatment (Blood Transfusion, Pharmacotherapy, and Bone Marrow Transplant), By End-Use (Hospitals, Specialty Clinics), By Country and Growth Forecast, 2023 - 2030

This report can be of interest as well:

LAMEA Sickle Cell Disease Treatment Market Size, Share & Industry Trends Analysis Report By Treatment (Blood Transfusion...

Published: August, 2023 | Report code: ASDR-659466